Login / Signup
André T S Vicente
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 4
Top Topics
Locally Advanced
Drug Discovery
Climate Change
Tyrosine Kinase
Top Venues
MedComm
Expert opinion on therapeutic patents
International journal of molecular sciences
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
André T S Vicente
,
Jorge A R Salvador
PROteolysis-Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives.
MedComm
5 (6) (2024)
André T S Vicente
,
Jorge A R Salvador
PROteolysis-Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives.
MedComm
5 (6) (2024)
André T S Vicente
,
Jorge A R Salvador
Proteolysis-Targeting Chimeras (PROTACs) targeting the BCR-ABL for the treatment of chronic myeloid leukemia - a patent review.
Expert opinion on therapeutic patents
(2023)
André T S Vicente
,
Jorge A R Salvador
MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment.
International journal of molecular sciences
23 (19) (2022)